{
  "id": "exome",
  "title": "Exome",
  "lang": "en",
  "source_lang": "en",
  "summary": "The exome is the collection of exonic sequences in a genome, commonly studied through sequencing focused on protein-coding regions.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/exome/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/exome/",
      "json": "https://aiwiki.page/zh/exome.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "The exome is the complete set of exons in a genome: the portions of genes retained in mature RNA after processing. In research and clinical practice, the term most often refers to the protein-coding exons targeted by exome sequencing, rather than every exonic sequence in the strict biological sense. The human protein-coding exome occupies approximately 1–2% of the nuclear genome, yet contains many variants with established effects on inherited disease. Its relatively small size makes it a practical target for investigating genetic variation."
    },
    {
      "heading": "Biological definition",
      "text": "In many eukaryotic genes, exons are separated by introns. During transcription, both are copied into an initial RNA molecule; RNA splicing removes introns and joins exons. In protein-coding genes, the resulting mature messenger RNA contains the sequence used to direct protein synthesis.\n\nAn exon is not necessarily entirely protein-coding. Exons can include untranslated regions at the beginning and end of a messenger RNA, and genes producing functional noncoding RNAs also contain exonic sequences. Consequently, the complete set of exons is conceptually broader than the complete set of protein-coding sequences. Published exome sizes and sequencing targets depend on which of these definitions is used.\n\nExon boundaries also depend on the transcript being considered. Through alternative splicing, a single gene can produce multiple RNA forms with different combinations of exons. A genomic segment may be retained in one transcript and removed in another. Defining an exome therefore requires a gene annotation: an organized description of genes, transcript structures, and their genomic coordinates. Revised annotations can change the set of regions designated as exonic.\n\nThe exome is a subset of genomic DNA, not a measurement of which genes are active. It differs from the transcriptome, the collection of RNA transcripts present in a biological sample. Most cells in an individual share broadly the same inherited exome, whereas their RNA composition varies substantially with cell type, developmental stage, and physiological conditions. RNA sequencing measures this expressed RNA population rather than directly surveying the genomic exome."
    },
    {
      "heading": "Exome sequencing",
      "text": "Exome sequencing, often called whole-exome sequencing or WES, is a form of DNA sequencing that enriches selected exonic regions before reading their nucleotide sequences. “Whole” describes the intended breadth of the target, not a guarantee that every exon is successfully analyzed.\n\nA typical workflow has several stages:\n\n- DNA preparation. DNA is extracted from a sample and prepared as a library of fragments with sequencing adapters.\n- Target enrichment. Synthetic probes bind complementary sequences in the selected regions. These fragments are isolated, increasing their representation relative to the rest of the genome. Some methods instead use targeted amplification.\n- Sequencing. The enriched library is sequenced, usually producing many short reads from each adequately captured region.\n- Computational analysis. Reads are aligned to a reference genome, sequence differences are identified, and the resulting variants are annotated and filtered.\n\nCapture designs commonly include coding exons and nearby splice junctions. Some also target untranslated regions or other selected sequences. Results therefore depend partly on the capture design, reference assembly, and annotation version used.\n\nTwo important quality measures are depth, the number of reads covering a position, and breadth of coverage, the proportion of target positions meeting a specified coverage threshold. A high average depth does not establish that every clinically or biologically important exon has been adequately covered."
    },
    {
      "heading": "What exome data reveal",
      "text": "Exome sequencing is particularly effective for detecting single-nucleotide substitutions and small insertions or deletions in well-covered target regions. Such variants can alter an amino acid, introduce a premature stop signal, disrupt the reading frame, or affect RNA splicing.\n\nNot every coding variant changes the resulting protein. Synonymous substitutions preserve the encoded amino acid, although some can affect splicing, RNA stability, or translation. Conversely, a protein-altering variant is not necessarily harmful. Its significance depends on the affected gene, molecular consequence, inheritance pattern, frequency in populations, and other evidence.\n\nSome analysis pipelines also detect deletions or duplications by comparing read depth across exons. This extends the information available from an exome, but performance varies with the size and location of the change, capture quality, and analytical method.\n\nExome data can also reveal mosaicism, in which a variant occurs in only a proportion of cells. Detection depends on its abundance in the sampled tissue, sequencing depth, and error characteristics. A variant absent from one tissue sample may still occur elsewhere in the body."
    },
    {
      "heading": "Research and clinical uses",
      "text": "Exome sequencing became an important discovery method in the late 2000s as high-throughput sequencing and target-enrichment methods developed. Early studies demonstrated that sequencing coding regions across affected individuals could identify genes responsible for rare inherited disorders.\n\nIn rare-disease research and clinical genetics, exomes are used to investigate possible genetic explanations for a phenotype. Comparing an affected individual with both biological parents—a trio analysis—can help distinguish inherited variants from newly arising variants and clarify inheritance patterns. Other family structures can provide additional evidence.\n\nIn cancer research, comparison of tumor and non-tumor samples helps distinguish acquired tumor variants from inherited variation. Exome data can identify coding changes affecting tumor biology, although interpretation is complicated by mixtures of cell populations and changes in chromosome copy number.\n\nLarge population studies use exome sequencing to characterize rare coding variation and examine associations with traits. These studies complement genome-wide association studies, which often survey common variants across both coding and noncoding regions.\n\nA central distinction is between detecting a variant and establishing its significance. Finding a rare variant in a plausible gene does not by itself establish causation. Interpretation combines technical evidence with population data, inheritance, functional studies, and the established relationship between a gene and a phenotype."
    },
    {
      "heading": "Limitations and comparison with other approaches",
      "text": "Exome sequencing samples only a small part of the genome. It generally provides limited information about distant regulatory sequences, deep intronic regions, and other noncoding DNA. Variants in these regions can affect gene expression or RNA processing without changing a coding sequence directly.\n\nOther limitations include:\n\n- Uneven capture: GC-rich sequences, repetitive regions, and some exons may receive insufficient coverage.\n- Ambiguous alignment: Reads from highly similar genes or pseudogenes may be difficult to assign correctly.\n- Incomplete detection of complex variation: Repeat expansions, balanced rearrangements, and many structural changes are not reliably characterized by standard exome workflows.\n- Interpretive uncertainty: Available evidence may be insufficient to classify a detected variant as disease-causing or benign.\n\nWhole-genome sequencing avoids exon-specific capture and surveys coding and noncoding regions more broadly, often with more uniform coverage. Its interpretation and technical performance nevertheless remain dependent on sequencing technology and analytical methods. Targeted gene panels examine a narrower set of genes and may provide deeper coverage or specialized analysis for a particular application.\n\nA negative exome result therefore does not exclude a genetic explanation for a condition. It can reflect a variant outside the target regions, a technical detection limit, or an incomplete understanding of gene function. Reanalysis can yield different interpretations as annotations, disease associations, and analytical methods change."
    },
    {
      "heading": "Data interpretation and governance",
      "text": "Exome analysis can uncover findings unrelated to the original reason for testing. Handling such findings involves consent, reporting policies, and data privacy. Genomic data can reveal information relevant to biological relatives as well as to the sampled individual.\n\nPopulation representation also affects interpretation. If an ancestry group is underrepresented in reference datasets, estimates of variant frequency may be less informative, increasing uncertainty about whether a rare observation is medically significant. The usefulness of exome sequencing therefore depends not only on sequence quality but also on the breadth and reliability of the evidence used to interpret it."
    }
  ],
  "links": [
    "exon",
    "genome",
    "eukaryote",
    "intron",
    "transcription-biology",
    "rna",
    "rna-splicing",
    "messenger-rna",
    "alternative-splicing",
    "dna",
    "rna-sequencing",
    "dna-sequencing",
    "amino-acid",
    "protein",
    "mosaicism",
    "phenotype",
    "cancer",
    "genome-wide-association-study",
    "causation",
    "gene-expression",
    "data-privacy"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}